Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter H van Geffen

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
The European Respiratory Journal|June 11, 2026
ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adultsMarkus Fally, Catia Cilloniz, John Linnell, et al.
Lung Cancer (Amsterdam, Netherlands)|June 6, 2025
AGREE-II appraisal of lung cancer management clinical practice guidelines by the OPTIMA consortiumSindhu Bhaarrati Naidu, Amyn Bhamani, Charlotte Murray, et al.
Lung Cancer (Amsterdam, Netherlands)|September 4, 2025
Clinical risk factors for developing brain metastases during first-line (chemo-)immunotherapy in patients with non-small cell lung cancer without known baseline brain metastasesJarno W J Huijs, Anna M Sadowska, Juliette H R J Degens, et al.
Lung Cancer (Amsterdam, Netherlands)|July 9, 2025
Corrigendum to "AGREE-II appraisal of lung cancer management clinical practice guidelines by the OPTIMA consortium". [Lung Cancer 205 (2025) 108610]Sindhu Bhaarrati Naidu, Amyn Bhamani, Charlotte Murray, et al.
The European Respiratory Journal|April 16, 2026
Reply regarding the European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancerAlessandro Brunelli, Georgia Hardavella, Rudolf M Huber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 20, 2023
Lung Cancer in IndonesiaOke Dimas Asmara, Eric Daniel Tenda, Gurmeet Singh, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2026
Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumabYan Wang, Laura H Bukkems, Johan G C van Hasselt, et al.
ERJ Open Research|October 21, 2022
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) <i>versus</i> intercalated TKI with chemotherapy for <i>EGFR</i>-mutated nonsmall cell lung cancerRolof G P Gijtenbeek, Vincent van der Noort, Joachim G J V Aerts, et al.
Plos One|August 12, 2022
Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patientsAbraham Rutgers, Peter E Westerweel, Bronno van der Holt, et al.
The European Respiratory Journal|November 13, 2025
European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancerAlessandro Brunelli, Georgia Hardavella, Rudolf M Huber, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The European Respiratory Journal|June 11, 2026
ERS statement: Core outcome set for trials evaluating the management of community-acquired and nosocomial pneumonia in adultsMarkus Fally, Catia Cilloniz, John Linnell, et al.
Lung Cancer (Amsterdam, Netherlands)|June 6, 2025
AGREE-II appraisal of lung cancer management clinical practice guidelines by the OPTIMA consortiumSindhu Bhaarrati Naidu, Amyn Bhamani, Charlotte Murray, et al.
Lung Cancer (Amsterdam, Netherlands)|September 4, 2025
Clinical risk factors for developing brain metastases during first-line (chemo-)immunotherapy in patients with non-small cell lung cancer without known baseline brain metastasesJarno W J Huijs, Anna M Sadowska, Juliette H R J Degens, et al.
Lung Cancer (Amsterdam, Netherlands)|July 9, 2025
Corrigendum to "AGREE-II appraisal of lung cancer management clinical practice guidelines by the OPTIMA consortium". [Lung Cancer 205 (2025) 108610]Sindhu Bhaarrati Naidu, Amyn Bhamani, Charlotte Murray, et al.
The European Respiratory Journal|April 16, 2026
Reply regarding the European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancerAlessandro Brunelli, Georgia Hardavella, Rudolf M Huber, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 20, 2023
Lung Cancer in IndonesiaOke Dimas Asmara, Eric Daniel Tenda, Gurmeet Singh, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2026
Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumabYan Wang, Laura H Bukkems, Johan G C van Hasselt, et al.
ERJ Open Research|October 21, 2022
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) <i>versus</i> intercalated TKI with chemotherapy for <i>EGFR</i>-mutated nonsmall cell lung cancerRolof G P Gijtenbeek, Vincent van der Noort, Joachim G J V Aerts, et al.
Plos One|August 12, 2022
Timely administration of tocilizumab improves outcome of hospitalized COVID-19 patientsAbraham Rutgers, Peter E Westerweel, Bronno van der Holt, et al.
The European Respiratory Journal|November 13, 2025
European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancerAlessandro Brunelli, Georgia Hardavella, Rudolf M Huber, et al.
Pageof 7